Impressive Revenue Growth
Second quarter revenue of $669 million increased 33% year-over-year, marking the 14th consecutive quarter of over 25% revenue growth.
Strong Bookings and Product Adoption
Closed almost $150 million of bookings for the AI Era Plan in Q2 alone, with over 30% of bookings this quarter coming from new product categories. Draft One, TASER 10, and Axon Body 4 are the fastest adopted products.
Record-Breaking Deals
The state and local team achieved the largest deal in Axon company history, and the corrections team also closed their largest deal in team history.
International Expansion
Added a new TASER customer in Africa, becoming the largest in the region, and signed a contract in the gaming space, marking the first win in that vertical to include AI products.
Raising Guidance
2025 revenue guidance raised to $2.65 billion to $2.73 billion, representing approximately 29% annual growth at the midpoint. Adjusted EBITDA guidance raised to $665 million to $685 million.